Gurdane Bhutani
Listed on 7 Form D filings across 7+ issuers
· Director, Executive Officer
Associated issuers
- Neurofold Therapeutics Inc. CIK 2145237 · CO
- Contraline, Inc. CIK 1818752 · VA
- Junction Health, Inc. CIK 2031239 · CO
- Ancilia Biosciences, Inc. CIK 1975776 · NY
- Capsule 20, a series of MBX Capital Opportunities I LLC CIK 2115859 · DE
- MBX Capital NYS SSBCI Fund, LP CIK 2059842 · DE
- MBX Capital III-A LP CIK 2060060 · DE
Filings (7)
-
Neurofold Therapeutics Inc.D · Jul 14, 2026 · CO · Biotechnology$6.5MView filing →
-
Contraline, Inc.D · Jun 10, 2026 · VA · Biotechnology$115.9MView filing →
-
Junction Health, Inc.D · May 22, 2026 · CO · Other Health Care$3.6MView filing →
-
Ancilia Biosciences, Inc.D · Apr 6, 2026 · NY · Other$10.1MView filing →
-
Capsule 20, a series of MBX Capital Opportunities I LLCD · Mar 11, 2026 · DE · Pooled Investment Fund
-
MBX Capital NYS SSBCI Fund, LPD · Mar 13, 2025 · DE · Pooled Investment Fund$6MView filing →
-
MBX Capital III-A LPD · Mar 11, 2025 · DE · Pooled Investment Fund$1.4MView filing →